Results 191 to 200 of about 4,884,808 (294)
Revisiting Pre-RAI MLR, PNI, and NRI Estimating Early and Higher Recurrence in Intermediate-Risk DTC in Thyroidology. [PDF]
Sengul I, Sengul D.
europepmc +1 more source
(A) Overview of the study population and schematic illustration showing tumor‐derived apoptotic and metabolic biomarkers, Apo10 and TKTL1, being phagocytosed by circulating monocytes and subsequently detected in peripheral blood. (B) Illustration of the epitope detection in monocytes (EDIM) strategy, using a flow‐cytometric gating approach based on ...
Zhiying Mao +8 more
wiley +1 more source
Cellular Senescence-Associated Gene Expression in Circulating CD4<sup>+</sup>, CD8<sup>+</sup>, CD19<sup>+</sup> Lymphocytes of HNSCC Patients: Associations with Clinical Parameters. [PDF]
Ostrowska K +14 more
europepmc +1 more source
Lymphoma is a group of blood cancers that can appear in lymph nodes, blood, bone marrow, spleen, liver, or the central nervous system, which makes drug delivery and disease monitoring difficult. This review summarizes how nanomedicine technologies may improve targeted treatment and imaging, while carefully separating approved or guideline‐supported ...
Mohd Ahmar Rauf +5 more
wiley +1 more source
Biopolymer‐Based Polyelectrolyte Nanoplatforms for Targeted Photodynamic Therapy of Breast Cancer
Illustration of the synthesis of 5‐aminolevulinic acid loaded chitosan‐sericin polyelectrolyte nanoparticles (CSSN/ALA NPs) using the Flash nanocomplexation (FNC) technique and their potential in photodynamic therapy (PDT) against breast cancer (BC). Abstract Nanomedicine has reshaped healthcare, especially in targeted drug delivery systems (DDSs) and ...
Athira Narayanan +14 more
wiley +1 more source
Clinical utility of circulating tumor-derived endothelial cells in lung cancer detection and prognosis prediction. [PDF]
Li X +6 more
europepmc +1 more source
ABSTRACT With the approval of immunotherapies by regulatory bodies, head and neck squamous cell carcinoma (HNSCC) treatment has been revolutionized, and anti‐programmed cell death‐1 (anti‐PD‐1) agents are now the standard for platinum‐resistant recurrent/metastatic HNSCC.
Xiao‐Tong Yan +2 more
wiley +1 more source
CAR T cells against the B cell receptor to precisely eliminate pathogenic B cells. [PDF]
Bochi-Layec AC +3 more
europepmc +1 more source
There is no consensus on surgical techniques in small bowel cancer, particularly regarding the extent of lymph node dissection and strategic choices according to tumor localization and histological type. Clearance of central lymph node metastases can be challenging, especially when small intestinal neuroendocrine tumor (siNET) metastases give rise to ...
Erik Kjæstad +6 more
wiley +1 more source
Diagnostic efficacy of circulating tumor cell in clinically significant prostate cancer. [PDF]
Qian J +6 more
europepmc +1 more source

